# 13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico

> **NCT01432262** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 324 (actual)

## Conditions studied

- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** vaccine-13vPnC
- **BIOLOGICAL:** vaccine-13vPnC

## Key facts

- **NCT ID:** NCT01432262
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 324 (ACTUAL)
- **Last updated:** 2013-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01432262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01432262, "13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01432262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*